NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE CHEMOTHERAPY FOUNDATION INC, founded in 1968, is a micro nonprofit that reported $80K in total revenue in fiscal year 2023. Revenue fell 55% from the prior year — a significant decline worth monitoring. Expenses of $375K exceeded revenue, resulting in a 371% operating deficit.
OUR MISSION IS TO STIMULATE THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE THERAPIES FOR THE TREATMENT, CONTROL, CURE, AND PREVENTION OF CANCER. THIS MISSION IS ACCOMPLISHED THROUGH GRANTS TO FUND CLINICAL AND SCIENTIFIC RESEARCH.
RESEARCH GRANT PROGRAMTHE GRANT PROGRAM FOCUSES ON SUPPORTING BASIC SCIENCE AND CLINICAL RESEARCH WITH TRANSLATIONAL POTENTIAL FOR NEAR-TERM BENEFIT TO IMPROVE PATIENT CARE AND SURVIVAL. THE...
RESEARCH GRANT PROGRAMTHE GRANT PROGRAM FOCUSES ON SUPPORTING BASIC SCIENCE AND CLINICAL RESEARCH WITH TRANSLATIONAL POTENTIAL FOR NEAR-TERM BENEFIT TO IMPROVE PATIENT CARE AND SURVIVAL. THE INNOVATIVE STUDIES OF SELECTED PRINCIPAL INVESTIGATORS AT MAJOR NEW YORK CITY MEDICAL CENTERS INCLUDE BRAIN TUMORS, BREAST CANCER, GASTROINTESTINAL CANCER, HEMATOLOGY MALIGNANCIES, AND, MALIGNANT MELANOMA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $79,579 | $178,027 | -0.6% |
| Expenses | $374,746 | $463,847 | -0.2% |
| Net Income | $-295,167 | $-285,820 | +0.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHAEL G ROSENBERG | CHAIR OF THE BOARD | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| CRAIG J GOLDBERG | TREASURER/SECRETARY | 2.00 |
Director
|
$0 | $0 | $0 |
| PETER ALKALAY | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| SUZANNE M MILLER PHD | TRUSTEE | 2.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM K OH | TRUSTEE | 2.00 |
Director
|
$0 | $0 | $0 |
| ERIC S RICHTER | TRUSTEE | 2.00 |
Director
|
$0 | $0 | $0 |
| TALIA BIRAN | TRUSTEE | 2.00 |
Director
|
$0 | $0 | $0 |
| PAOLA G MUGGIA | EXECUTIVE DIRECTOR | 50.00 |
Officer
|
$120,000 | $0 | $120,000 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | No data | No data | No data | No data |
| 2023 | $79,579 | $374,746 | $317,311 | $-295,167 |
| 2022 | $178,027 | $463,847 | $509,696 | $-285,820 |
| 2021 | $563,954 | $627,801 | $857,401 | $-63,847 |
| 2020 | $167,301 | $430,444 | $915,123 | $-263,143 |
| 2019 | $330,202 | $1,019,751 | $1,305,022 | $-689,549 |
| 2018 | $470,966 | $1,108,269 | $1,910,388 | $-637,303 |
Compare THE CHEMOTHERAPY FOUNDATION INC with other nonprofits in New York and across the country.